GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

picankibart   Click here for help

GtoPdb Ligand ID: 14398

Synonyms: IBI 112 | IBI-112 | IBI112 | Pecondle® (China)
Approved drug
picankibart is an approved drug
Compound class: Antibody
Comment: Picankibart (IBI112) is a humanized monoclonal antibody that targets human IL-23A p19 subunit, for anti-inflammatory potential [1]. The antibody neutralises IL-23-mediated receptor signalling and blocks downstream signal transducer and activator of transcription 3 (STAT3) phosphorylation and IL-17 production.
No information available.
Summary of Clinical Use Click here for help
First approval was granted by China's NMPA in 2025, to treat moderate-to-severe plaque psoriasis.